• Drug Pricing Fears Erase Biotech Stock Gains for the Year

    Sep 29, 2015, 10:42 AM by Michael Croft
    The Street | Anger over a price hike at Turing Pharmaceuticals and a Congressional letter to Valeant have dealt a blow to biotech stocks that many observers already fretted were sharply overvalued.
    Full story
  • CONGENICA AWARDED £300k INNOVATE UK GRANT TO UNLOCK STRATIFIED MEDICINE LIFE SCIENCES MINISTER ANNOUNCES

    Sep 29, 2015, 08:37 AM by Michael Croft
    CAMBRIDGE UK, UK - Sep 29, 2015 - Life Sciences Minister George Freeman MP today announced at the GREAT Healthcare Week at the Milan Expo, that Congenica, a world leading developer of genome-based discovery and diagnostic technologies, has been awarded £300,000 by Innovate UK as part of its ‘Finding value in complex data’ competition
    Full story
  • Tour of the Cloud: Emerald Cloud Labs’ Hardware and Software Vision

    Sep 28, 2015, 09:30 AM by Michael Croft
    Bio-IT World | Emerald Cloud Labs' robotics facility for programmable scientific experiments is up and running in South San Francisco, as Bio-IT World editor Allison Proffitt reports from inside the lab.
    Full story
  • FDA Turns Its Eye on Pathway's 'Direct-to-Consumer' Cancer Test

    Sep 25, 2015, 15:15 PM by Michael Croft
    Diagnostics World | This Thursday, the FDA sent a letter to Pathway Genomics warning the company that a newly introduced test, a liquid biopsy to find early-stage cancer in apparently healthy people, has not been clinically validated and could be harmful to public health. The letter not only calls attention to the shaky evidence for this test's accuracy, but also asserts the FDA's authority over a whole category of tests in a regulatory gray area.
    Full story
  • Farewell Nabsys

    Sep 25, 2015, 11:06 AM by Michael Croft
    Omics! Omics! Blog | Nabsys and its all-electronic single molecule physical mapping approach closed its doors a little over a week ago.
    Full story
  • Bring your companys dark data to light with this free new tool from Tamr

    Sep 24, 2015, 16:37 PM by Michael Croft
    Computerworld | Tamr's enterprise metadata catalog can help companies create an inventory of their data sources, including metadata about who owns the source.
    Full story
  • Affordable large-scale DNA variation studies for every DNA researcher

    Sep 24, 2015, 09:31 AM by Michael Croft
    HARDERWIJK, THE NETHERLANDS - Sep 24, 2015 - Today, GENALICE announced the global launch date of Population Calling, a new analysis module and part of their GENALICE MAP Next-Generation Sequencing (NGS) Data Analysis Suite
    Full story
  • IBM to open San Francisco office dedicated to Watson supercomputing

    Sep 24, 2015, 09:00 AM by Michael Croft
    Fortune | IBM plans to open a new San Francisco office next year dedicated to growing its Watson supercomputing business. The location will give IBM direct access to the Bay Area startups.
    Full story
  • Venter's HLI Opens Genome Sequencing Service

    Sep 23, 2015, 14:50 PM by Michael Croft
    San Diego Union-Tribune | Craig Venter's latest company, Human Longevity, Inc., has announced a partnership with health insurer Discovery Ltd. of the U.K. and South Africa to offer patients whole exome sequencing for $250, a service Venter hopes to extend to the U.S.
    Full story
  • Garvan Institute Uses Panasas System for X Ten

    Sep 21, 2015, 13:00 PM by Michael Croft
    Bio-IT World  | The Garvan Institute of Medical Research in Sydney was one of the first three groups to sign up for Illumina’s HiSeq X Ten sequencing platform in 2014, a system that produced up to 5TB of data per day. To enable round the clock computing with as little down time as possible, the Institute opted for the Panasas PanFS parallel file system.
    Full story
  • British Scientists Seek Permission To Edit DNA In Human Embryos

    Sep 18, 2015, 12:21 PM by Michael Croft
    NPR.org | After Chinese scientists announced in April that they had edited the genes in human embryos, many researchers said it shouldn't be done. Scientists in London say they want to do it for research only.
    Full story
  • Under the Hood with Edico’s DRAGEN Card at HudsonAlpha

    Sep 18, 2015, 09:00 AM by Michael Croft
    Bio-IT World | Two weeks before Edico was ready to go public, Shawn Levy of HudsonAlpha was happily telling us of his expereince with Edico's DRAGEN card, a bio-IT processor that claims to massively accelerate secondary analysis algorithms while simultaneously improving accuracy. Levy calls it--in a word--amazing.
    Full story
  • CSM to Celebrate Grand Opening of New Malvern Facility

    Sep 17, 2015, 17:32 PM by Michael Croft
    MALVERN, PA - Sep 17, 2015 - CSM is pleased to announce that it will hold a Grand Opening and Ribbon-Cutting ceremony for its newly constructed facility at 300 Technology Drive in the Great Valley Corporate Center of Malvern, Pennsylvania on Thursday, October 15th from 1 p
    Full story
  • Long-lived Smokers: A ‘Biologically Distinct’ Group with Extraordinary Gene Variants

    Sep 16, 2015, 11:21 AM by Michael Croft
    Washington Post | Researchers say they've identified a set of genetic variants that may here is evidence that these genes may facilitate lifespan extension by increasing cellular maintenance and repair.
    Full story
  • Head of Mental Health Institute Leaving for Google Life Sciences

    Sep 15, 2015, 13:17 PM by Michael Croft
    The New York Times | Dr. Thomas R. Insel announced that he is stepping down after 13 years as director of the National Institute of Mental Health to join Google Life Sciences.
    Full story
  • Imprecision Medicine: Eric Dishman Kicked Off the Converged IT Summit

    Sep 15, 2015, 09:00 AM by Michael Croft
    Bio-IT World Eric Dishman, an Intel Fellow and general manager of the Health and Life Sciences for the Data Center Group, shared his own precision medicine story at the inaugural Converged IT Summit* co-hosted by the BioTeam and Cambridge Healthtech Institute, setting the tone for a two-day look at trends from the trenches of IT and life sciences discovery.
    Full story
  • Bio-specimen Grant Program Launched

    Sep 14, 2015, 14:02 PM by Michael Croft
    MINNEAPOLIS, MN, UNITED STATES - Sep 14, 2015 - DaVita Clinical Research® (DCR®), a specialty contract research organization with services spanning a broad spectrum of drug and device development, announced today its Biospecimen ResearchGrant Program (BioReG), a grant program to award clinical-trial-quality biospecimens and annotated de-identified data to academic medical centers involved in kidney research
    Full story
  • Genedata at SBI2 will Showcase How Genedata Screener Industrializes HCS

    Sep 14, 2015, 10:58 AM by Michael Croft
    CAMBRIDGE, MA, UNITED STATES - Sep 14, 2015 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, announced it will be among the presenters at the 2nd Annual Society of Biomolecular Imaging and Informatics (SBI2) Meeting
    Full story
  • Gene Therapy Startup Dimension Tx Takes Crossover Cash to IPO Queue

    Sep 14, 2015, 09:56 AM by Michael Croft
    Xconomy | Time to add one more recipient of crossover investor cash to the list of official IPO candidates. Cambridge, MA-based Dimension Therapeutics just filed for an IPO this morning to raise money to build gene therapies for rare diseases.
    Full story
  • Government Incentive Programs to Boost the E-Prescribing Market

    Sep 14, 2015, 05:37 AM by Michael Croft
    ALBANY, NY - Sep 14, 2015 - E-Prescribing is the system to broadcast information related to prescription among prescriber, dispenser, and pharmacy benefit manager electronically that allows a doctor and nurse to broadcast a new prescription electronically when any error in medication takes place at any stage in pharmacy operations
    Full story